Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Animal Study To Evaluate Potential Therapeutic Effect Of Dehydratech-...
(MENAFN- Investor Brand Network) Lexaria Bioscience has launched DEM-A22-1, its first-ever study to investigate whether its patented DehydraTECH(TM)-processed CBD may have therapeutic use against dementia The animal study will involve a total of 32 Long …